345 related articles for article (PubMed ID: 22796097)
1. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
[TBL] [Abstract][Full Text] [Related]
2. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).
Sakaguchi H; Ashikaga T; Miyazawa M; Kosaka N; Ito Y; Yoneyama K; Sono S; Itagaki H; Toyoda H; Suzuki H
Cell Biol Toxicol; 2009 Apr; 25(2):109-26. PubMed ID: 18204907
[TBL] [Abstract][Full Text] [Related]
3. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1.
Sakaguchi H; Miyazawa M; Yoshida Y; Ito Y; Suzuki H
Arch Dermatol Res; 2007 Feb; 298(9):427-37. PubMed ID: 17119987
[TBL] [Abstract][Full Text] [Related]
4. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
[TBL] [Abstract][Full Text] [Related]
5. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT.
Sakaguchi H; Ashikaga T; Miyazawa M; Yoshida Y; Ito Y; Yoneyama K; Hirota M; Itagaki H; Toyoda H; Suzuki H
Toxicol In Vitro; 2006 Aug; 20(5):774-84. PubMed ID: 16337770
[TBL] [Abstract][Full Text] [Related]
6. Artificial neural network analysis of data from multiple in vitro assays for prediction of skin sensitization potency of chemicals.
Hirota M; Kouzuki H; Ashikaga T; Sono S; Tsujita K; Sasa H; Aiba S
Toxicol In Vitro; 2013 Jun; 27(4):1233-46. PubMed ID: 23458967
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT).
Nukada Y; Ashikaga T; Sakaguchi H; Sono S; Mugita N; Hirota M; Miyazawa M; Ito Y; Sasa H; Nishiyama N
Contact Dermatitis; 2011 Dec; 65(6):343-53. PubMed ID: 21767275
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization.
Hirota M; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Takenouchi O; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1333-47. PubMed ID: 25824844
[TBL] [Abstract][Full Text] [Related]
9. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
10. Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals.
Nukada Y; Miyazawa M; Kazutoshi S; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Mar; 27(2):609-18. PubMed ID: 23149339
[TBL] [Abstract][Full Text] [Related]
11. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro.
Mitjans M; Galbiati V; Lucchi L; Viviani B; Marinovich M; Galli CL; Corsini E
Toxicol In Vitro; 2010 Sep; 24(6):1803-9. PubMed ID: 20541004
[TBL] [Abstract][Full Text] [Related]
12. Performance standards and alternative assays: practical insights from skin sensitization.
Kolle SN; Basketter DA; Casati S; Stokes WS; Strickland J; van Ravenzwaay B; Vohr HW; Landsiedel R
Regul Toxicol Pharmacol; 2013 Mar; 65(2):278-85. PubMed ID: 23279805
[TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA).
Ashikaga T; Sakaguchi H; Sono S; Kosaka N; Ishikawa M; Nukada Y; Miyazawa M; Ito Y; Nishiyama N; Itagaki H
Altern Lab Anim; 2010 Aug; 38(4):275-84. PubMed ID: 20822320
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of the human Cell Line Activation Test (h-CLAT) to Animal-Product-Free Conditions.
Edwards A; Roscoe L; Longmore C; Bailey F; Sim B; Treasure C
ALTEX; 2018; 35(4):477-488. PubMed ID: 29901211
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol.
Ashikaga T; Yoshida Y; Hirota M; Yoneyama K; Itagaki H; Sakaguchi H; Miyazawa M; Ito Y; Suzuki H; Toyoda H
Toxicol In Vitro; 2006 Aug; 20(5):767-73. PubMed ID: 16311011
[TBL] [Abstract][Full Text] [Related]
16. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
17. Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
An S; Kim S; Huh Y; Lee TR; Kim HK; Park KL; Eun HC
Contact Dermatitis; 2009 Apr; 60(4):185-92. PubMed ID: 19338585
[TBL] [Abstract][Full Text] [Related]
18. Cross talk between keratinocytes and dendritic cells: impact on the prediction of sensitization.
Hennen J; Aeby P; Goebel C; Schettgen T; Oberli A; Kalmes M; Blömeke B
Toxicol Sci; 2011 Oct; 123(2):501-10. PubMed ID: 21742781
[TBL] [Abstract][Full Text] [Related]
19. Development of an in vitro skin sensitization test based on ROS production in THP-1 cells.
Saito K; Miyazawa M; Nukada Y; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Mar; 27(2):857-63. PubMed ID: 23287046
[TBL] [Abstract][Full Text] [Related]
20. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
